The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 01, 2020
Filed:
Jul. 23, 2016
Applicants:
University of Houston System, Houston, TX (US);
University of Texas Southwestern Medical Center, Dallas, TX (US);
Inventors:
Damith Gomika Udugamasooriya, Katy, TX (US);
Rolf A. Brekken, Dallas, TX (US);
Assignees:
University of Houston System, Houston, TX (US);
Board of Regents of The University of Texas System, Austin, TX (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/343 (2006.01); A61K 38/00 (2006.01); A61K 31/337 (2006.01); A61K 49/00 (2006.01); A61K 47/55 (2017.01); A61P 35/00 (2006.01); G01N 33/50 (2006.01); G01N 33/53 (2006.01); G01N 33/543 (2006.01); G01N 33/574 (2006.01);
U.S. Cl.
CPC ...
A61K 31/343 (2013.01); A61K 31/337 (2013.01); A61K 38/00 (2013.01); A61K 47/55 (2017.08); A61K 49/0056 (2013.01); A61P 35/00 (2018.01); G01N 33/5044 (2013.01); G01N 33/5306 (2013.01); G01N 33/54393 (2013.01); G01N 33/574 (2013.01);
Abstract
A phosphatidylserine targeted peptoid has been identified with the ability to bind to cancer cells globally and specifically. A dimer of the peptoid decreases cancer cell viability. Use of the dimerized peptoid enhances the efficacy of docetaxel. The peptoid can be used for including but not limited to diagnosing and treating cancer, diagnosing and treating a viral condition, and diagnosing and treating diabetes.